Review
Published on 11 Nov 2024
EAF2: a tumor suppressor gene with multi-aspect functions
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1440511
- 127 views
Type at least 3 characters
2,595 articles
Articles
Original Research
Published on 11 Nov 2024
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1487940
- 136 views
Original Research
Accepted on 08 Nov 2024
Anti-Tumor and Anti-Metastatic Effects of RRx-001 on Hepatocellular Carcinoma: Mechanisms of Action and Therapeutic Potential
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1469825
Review
Published on 08 Nov 2024
Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431581
- 131 views
Original Research
Published on 08 Nov 2024
Prognostic characteristics and drug sensitivity analysis of hepatocellular carcinoma based on histone modification-related genes: a multi-omics integrated study revealing potential therapeutic targets and individualized treatment strategies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1489469
- 142 views
Original Research
Published on 07 Nov 2024
A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1489045
- 141 views
Review
Published on 07 Nov 2024
Inspired by an ancient Chinese Medicine prescription: the modern significance and potential of Yiyi Fuzi Baijiang San in treating diseases
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1465387
- 134 views
Original Research
Published on 06 Nov 2024
Tinosporae Radix attenuates acute pharyngitis by regulating glycerophospholipid metabolism and inflammatory responses through PI3K-Akt signaling pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491321
- 336 views
Methods
Accepted on 05 Nov 2024
Protocol of REACH-01: A single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1435639
Review
Published on 05 Nov 2024
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1475998
- 242 views
Systematic Review
Published on 05 Nov 2024
Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1451773
- 137 views
Review
Published on 05 Nov 2024
Emerging strategies to overcome ovarian cancer: advances in immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490896
- 242 views
Correction
Published on 04 Nov 2024
Corrigendum: Network-based prediction of anti-cancer drug combinations
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1495634
- 126 views
Case Report
Published on 01 Nov 2024
Case report: Treatment with ensartinib shows good response to SQSTM1-ALK fusion in lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433894
- 211 views
Original Research
Published on 01 Nov 2024
Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494131
- 261 views
Original Research
Published on 01 Nov 2024
Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500731
- 247 views